Entering text into the input field will update the search result below

GNW, IIPR among premarket losers

Jun. 30, 2020 8:15 AM ETFTEK, INO, GNW, TRIB, IBIO, VXRT, BIMI, EKSO, CLSK, ZYNE, BOXL, PDSB, PPBT, OCX, IIPR, LQDA, SOLO, PHCFFBy: SA News Team
  • OncoCyte (NYSEMKT:OCX-46% following unsuccessful results from a clinical validation study of DetermaDx.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE-40% after Zygel flunks Fragile X study.
  • Liquidia Technologies (NASDAQ:LQDA-20% after pricing equity offering.
  • Genworth Financial (NYSE:GNW-17% after extending merger agreement with Oceanwide.
  • Puhui Wealth Investment Management (NASDAQ:PHCF) -16%.
  • Inovio Pharmaceuticals (NASDAQ:INO-10%.
  • PDS Biotechnology (NASDAQ:PDSB) -10%.
  • Fuel Tech (NASDAQ:FTEK) -9%.
  • Electrameccanica Vehicles (NASDAQ:SOLO) -9%.
  • Trinity Biotech (NASDAQ:TRIB) -7%.
  • IBio (NYSEMKT:IBIO) -7%.
  • Kitov Pharma (NASDAQ:KTOV) -7%.
  • Vaxart (NASDAQ:VXRT) -7%.
  • Boxlight (NASDAQ:BOXL) -6%.
  • Ekso Bionics Holdings (NASDAQ:EKSO) -6%.
  • CleanSpark (NASDAQ:CLSK) -6%.
  • Innovative Industrial Properties (NYSE:IIPR-5% after pricing stock offering.
  • BOQI International Medical (NASDAQ:BIMI-5% on Q1 results.

Recommended For You

More Trending News